News for MyoKardia, Inc. (MYOK)

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines fo

**media[464672]**

Abivax Provides Operational and Key Program Update Phase 3 ABTECT Trial evaluating obefazimod in moderately to severely active ulcerative colitis (UC)...

― Entered into a collaboration and ex-U.S. license agreement with Sanofi for the development and commercialization of losmapimod ― ― On track to report...

KalVista Pharmaceuticals, Inc. , a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced that...

― On track to report topline data for Phase 3 REACH trial of losmapimod in facioscapulohumeral muscular dystrophy (FSHD) in the fourth quarter of 2024 ― ―...

LianBio shares surge following termination of Bristol Myers agreement

Cutera Appoints Taylor Harris as CEO

SHANGHAI, China and PRINCETON, N.J., July 17, 2023 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative...

GuruFocus Article or News written by GuruFocus Editor and the topic is about:

TN-201 Received Fast Track Designation from the FDA Dosing Complete in Phase 1 Clinical Trial of TN-301; Data Expected in Second Half 2023 Renowned...

Biotech Shares Have Soared Since 2020's Wave of IPOs, Stocks: AVIR,RHHBY,NKTX,LEGN,RNA,JNJ,LLY,MYOK,BMY,ABCL,RLA, release date:Feb 17, 2021

T. Rowe Price Equity Income Fund reduced stake in MGM Resorts International

T. Rowe Price Equity Income Fund increased stake in Yum Brands Inc

T. Rowe Price Equity Income Fund increased stake in SEACOR Holdings Inc.